|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
CAPMATINIB |
L01EX17 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
FARICIMAB |
S01LA09 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005642 |
15-09-2022 |
VALID
|
|
FOSDENOPTERIN |
A16AX19 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005378 |
15-09-2022 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
LASMIDITAN |
N02CC08 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005332 |
17-08-2022 |
VALID
|
|
LENACAPAVIR |
J05AX31 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
LONAFARNIB |
A16AX20 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005271 |
18-07-2022 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
RELUGOLIX |
L02BX04 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
ADALIMUMAB |
L04AB04 |
IT
|
II
|
12-07-2022 |
|
|
VALID
|
|
CIPROFLOXACIN |
J01MA02 |
IT
|
II
|
12-07-2022 |
|
11-02-2002 |
VALID
|
|
MOXIFLOXACIN |
J01MA14 |
IT
|
II
|
12-07-2022 |
|
|
VALID
|
|
NALOXONE |
V03AB15 |
IT
|
II + Exemption
|
12-07-2022 |
|
|
VALID
|
|
NORFLOXACIN |
J01MA06 |
IT
|
II
|
12-07-2022 |
|
11-02-2002 |
VALID
|
|
OFLOXACIN |
J01MA01 |
IT
|
Not authorised
|
12-07-2022 |
|
|
VALID
|
|
PEFLOXACIN |
J01MA03 |
IT
|
Not authorised
|
12-07-2022 |
|
|
VALID
|
|
PRULIFLOXACIN |
J01MA17 |
IT
|
II
|
12-07-2022 |
|
21-06-2004 |
VALID
|
|
THIAMAZOLE |
H03BB02 |
IT
|
II
|
12-07-2022 |
|
11-02-2002 |
VALID
|
|
VARIOUS |
R02AA20 |
IT
|
Not subject to prescription
|
12-07-2022 |
|
22-08-2003 |
VALID
|
|
LEVOFLOXACIN |
J01MA12 |
IT
|
II
|
11-07-2022 |
|
|
VALID
|
|
RUFLOXACIN |
J01MA10 |
IT
|
Not authorised
|
11-07-2022 |
|
|
VALID
|
|
ABROCITINIB |
D11AH08 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
ARTESUNATE |
P01BE03 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
AVACOPAN |
L04AJ05 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
FINERENONE |
C03DA05 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
LONAPEGSOMATROPIN |
H01AC09 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005367 |
11-01-2022 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
PRALSETINIB |
L01EX23 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
RIPRETINIB |
L01EX19 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005614 |
18-11-2021 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
SOMATROGON |
H01AC08 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005633 |
14-02-2022 |
VALID
|
